New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors

Item

http://www.wikidata.org/entity/Q36790050

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors

@ast

New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors

@en

type

Item

label

New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors

@ast

New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors

@en

prefLabel

New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors

@ast

New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors

@en

P1476

New pharmacologic therapies for gastroenteropancreatic neuroendocrine tumors

@en

P2093

Ben Lawrence

http://www.w3.org/2001/XMLSchema#string

Bjorn I Gustafsson

http://www.w3.org/2001/XMLSchema#string

Irvin Modlin

http://www.w3.org/2001/XMLSchema#string

Mark Kidd

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours

A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome

Gastroenteropancreatic neuroendocrine tumours

Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors.

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

An analysis of trends and growth factor receptor expression of GI carcinoid tumors

Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours.

Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.

P304

615-628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.GTC.2010.08.013

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47449220

http://www.w3.org/2001/XMLSchema#string

P698

20951920

http://www.w3.org/2001/XMLSchema#string

P932

3634348

http://www.w3.org/2001/XMLSchema#string